These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25971547)

  • 1. Decreased H2B monoubiquitination and overexpression of ubiquitin-specific protease enzyme 22 in malignant colon carcinoma.
    Wang Z; Zhu L; Guo T; Wang Y; Yang J
    Hum Pathol; 2015 Jul; 46(7):1006-14. PubMed ID: 25971547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased histone H2B monoubiquitination in malignant gastric carcinoma.
    Wang ZJ; Yang JL; Wang YP; Lou JY; Chen J; Liu C; Guo LD
    World J Gastroenterol; 2013 Nov; 19(44):8099-107. PubMed ID: 24307806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer.
    Zhang Y; Yao L; Zhang X; Ji H; Wang L; Sun S; Pang D
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1245-53. PubMed ID: 21691749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High USP22 expression indicates poor prognosis in hepatocellular carcinoma.
    Tang B; Tang F; Li B; Yuan S; Xu Q; Tomlinson S; Jin J; Hu W; He S
    Oncotarget; 2015 May; 6(14):12654-67. PubMed ID: 25909224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma.
    Wang H; Li YP; Chen JH; Yuan SF; Wang L; Zhang JL; Yao Q; Li NL; Bian JF; Fan J; Yi J; Ling R
    Tumour Biol; 2013 Jun; 34(3):1635-9. PubMed ID: 23412977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-specific peptidase 22, a histone deubiquitinating enzyme, is a novel poor prognostic factor for salivary adenoid cystic carcinoma.
    Dai W; Yao Y; Zhou Q; Sun CF
    PLoS One; 2014; 9(1):e87148. PubMed ID: 24466336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP22 nuclear expression is significantly associated with progression and unfavorable clinical outcome in human esophageal squamous cell carcinoma.
    Li J; Wang Z; Li Y
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1291-7. PubMed ID: 22447106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer.
    Hu J; Liu YL; Piao SL; Yang DD; Yang YM; Cai L
    Lung Cancer; 2012 Sep; 77(3):593-9. PubMed ID: 22717106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer.
    Ning J; Zhang J; Liu W; Lang Y; Xue Y; Xu S
    Eur J Histochem; 2012 Nov; 56(4):e46. PubMed ID: 23361242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma.
    Tang B; Liang X; Tang F; Zhang J; Zeng S; Jin S; Zhou L; Kudo Y; Qi G
    Int J Oncol; 2015 Dec; 47(6):2208-16. PubMed ID: 26497847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.
    Liu YL; Yang YM; Xu H; Dong XS
    J Gastroenterol Hepatol; 2010 Nov; 25(11):1800-5. PubMed ID: 21039844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics.
    Yang M; Liu YD; Wang YY; Liu TB; Ge TT; Lou G
    Tumour Biol; 2014 Feb; 35(2):929-34. PubMed ID: 23979981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma.
    Piao S; Liu Y; Hu J; Guo F; Ma J; Sun Y; Zhang B
    PLoS One; 2012; 7(8):e42540. PubMed ID: 22880026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance and prognostic value of Nek2 protein expression in colon cancer.
    Lu L; Zhai X; Yuan R
    Int J Clin Exp Pathol; 2015; 8(11):15467-73. PubMed ID: 26823916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FRZB up-regulation is correlated with hepatic metastasis and poor prognosis in colon carcinoma patients with hepatic metastasis.
    Shen Y; Zhang F; Lan H; Chen K; Zhang Q; Xie G; Teng L; Jin K
    Int J Clin Exp Pathol; 2015; 8(4):4083-90. PubMed ID: 26097596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
    Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
    Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
    Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
    Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of AT-rich interactive domain 3A (ARID3A) is associated with good prognosis in colorectal carcinoma.
    Song M; Kim H; Kim WK; Hong SP; Lee C; Kim H
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S481-9. PubMed ID: 24366420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-specific protease 22 is associated with poor prognosis in neuroblastoma.
    Zhibo Q; Lianxin L
    Adv Clin Exp Med; 2020 Mar; 29(3):295-300. PubMed ID: 32216173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.
    Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY
    Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.